Loading organizations...
Loading organizations...
Research and development of clinical drugs for immunity and ophthalmology.
Evergreen Therapeutics has raised $15.5M across 1 funding round.
Evergreen Therapeutics has raised $15.5M in total across 1 funding round.
Evergreen Therapeutics has raised $15.5M in total across 1 funding round.
Evergreen Therapeutics's investors include Guoxing Wei.
Evergreen Therapeutics has raised $15.5M across 1 funding round. Most recently, it raised $15.5M Series A in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 7, 2021 | $15.5M Series A | Guoxing Wei |